Go Pro
NASDAQ:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

Biotricity logo
$0.08 0.00 (-2.31%)
As of 09/18/2026 03:49 PM Eastern

About Biotricity Stock (NASDAQ:BTCY)

Advanced

Key Stats

Today's Range
$0.08
$0.10
50-Day Range
$0.08
$0.13
52-Week Range
$0.08
$0.75
Volume
35,512 shs
Average Volume
50,036 shs
Market Capitalization
$1.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biotricity, Inc. (NASDAQ: BTCY) is a medical technology company focused on remote cardiac monitoring and digital health solutions. The company develops connected medical devices, software and cloud-based platforms designed to help physicians collect, review and manage cardiac data outside traditional clinical settings.

Biotricity’s product portfolio has included Bioflux, an FDA-cleared mobile cardiac telemetry system for continuous electrocardiogram monitoring, as well as wearable and at-home cardiac monitoring technologies. Its solutions are intended to support the detection and management of arrhythmias and other heart-related conditions while improving communication between patients and healthcare providers.

Founded in 2013 and headquartered in Redwood City, California, Biotricity primarily serves the U.S. healthcare market through relationships with medical practices, healthcare providers and patients. The company was founded and is led by Waqaas Al-Siddiq, who serves as chief executive officer.

AI Generated. May Contain Errors.

Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BTCY Stock News Headlines

Biotricity Q3 2026 Earnings Call: Complete Transcript
Bezos… DOOMED
A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X combined - aimed at the $25 trillion AI industry. James Altucher says the plan could cut Amazon out of the AI race and disrupt Blue Origin, with a key deadline landing September 25.tc pixel
Biotricity, Inc. (BTCY) Q3 2026 Earnings Call Transcript
Biotricity Inc.
See More Headlines

BTCY Stock Analysis - Frequently Asked Questions

Biotricity's stock was trading at $0.30 at the beginning of the year. Since then, BTCY stock has decreased by 71.8% and is now trading at $0.0846.

Biotricity, Inc. (NASDAQ:BTCY) posted its quarterly earnings results on Wednesday, February, 11th. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.04. The business had revenue of $3.99 million for the quarter.
Read the conference call transcript
.

Biotricity's stock reverse split before market open on Monday, July 3rd 2023.The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Biotricity (BTCY) raised $15 million in an IPO on Thursday, August 26th 2021. The company issued 5,000,000 shares at a price of $3.00 per share. H.C. Wainwright & Co. acted as the underwriter for the IPO.

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Broadcom (AVGO), Micron Technology (MU) and Bank of America (BAC).

Company Calendar

Last Earnings
2/11/2026
Today
9/20/2026
Next Earnings (Estimated)
11/12/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:BTCY
Previous Symbol
OTCMKTS:BTCY
CIK
1630113
Fax
N/A
Employees
46
Year Founded
2014

Profitability

EPS (Trailing Twelve Months)
($0.14)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.09 million
Net Margins
-80.42%
Pretax Margin
-80.42%
Return on Equity
N/A
Return on Assets
-188.47%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.23
Quick Ratio
0.10

Sales & Book Value

Annual Sales
$12.06 million
Price / Sales
0.14
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.30) per share
Price / Book
-0.07

Miscellaneous

Outstanding Shares
20,075,000
Free Float
22,075,000
Market Cap
$1.70 million
Optionable
No Data
Beta
1.16

Social Links

10 Best Stocks to Own - Fall 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:BTCY) was last updated on 9/20/2026 by MarketBeat.com Staff.
From Our Partners